Filter
2162
Text search:
ART
drugs
Featured
Recommendations
174
New Publications
657
Language
Document type
No document type
1542
Guidelines
222
Studies & Reports
212
Manuals
65
Strategic & Response Plan
37
Training Material
33
Fact sheets
28
Infographics
9
Situation Updates
7
Brochures
4
Resource Platforms
3
Countries / Regions
India
140
Kenya
80
Zambia
64
South Africa
62
Tanzania
58
Ethiopia
54
Malawi
53
Nigeria
50
Uganda
46
Nepal
39
Rwanda
39
Western and Central Europe
36
Liberia
35
Myanmar / Burma
34
Global
33
Namibia
32
Ghana
31
Lesotho
30
Africa
30
Bangladesh
28
Sierra Leone
24
Ukraine
24
Eastern Europe
23
Asia
22
Zimbabwe
21
Cambodia
20
Latin America and the Carribbean
18
Senegal
17
Botswana
17
Philippines
16
South–East Asia Region
14
Mozambique
13
Eswatini/ Swaziland
13
Indonesia
11
Venezuela
9
Albania
9
Cameroon
8
Germany
8
Russia
8
Congo, Democratic Republic of
7
Tajikistan
7
Haiti
6
Pakistan
6
Syria
6
Brazil
6
Georgia
6
Burkina Faso
5
Colombia
5
Paraguay
5
Thailand
4
Benin
4
Yemen
4
East and Southern Africa
4
Armenia
4
Guinea
3
South Sudan
3
Afghanistan
3
Central African Republic
3
Argentina
3
West and Central Africa
3
Bhutan
3
Estonia
3
Romania
3
Vietnam
3
Somalia
2
Lebanon
2
Sudan
2
North Macedonia
2
Serbia
2
Ecuador
2
Sri Lanka
2
Middle East and North Africa
2
Timor Leste/ East Timor
2
Moldova
2
Uzbekistan
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
USA
1
Saudi Arabia
1
Niger
1
Iraq
1
Jordan
1
Egypt
1
Gambia
1
China
1
Papua New Guinea
1
Peru
1
Hungary
1
Burundi
1
Bolivia
1
Greece
1
Libya
1
Madagascar
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Poland
1
Palestine
1
North Korea
1
Djibouti
1
Southern Africa
1
Laos
1
Canada
1
Qatar
1
Bulgaria
1
Lithuania
1
Iran
1
Australia
1
Uruguay
1
Turkmenistan
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
985
Clinical Guidelines
173
Women & Child Health
71
Public Health
53
Capacity Building
51
Key Resources
45
Pharmacy & Technologies
17
Annual Report MEDBOX
1
Toolboxes
HIV
545
TB
241
Mental Health
108
Pharmacy
45
Caregiver
43
NTDs
31
COVID-19
27
AMR
26
Refugee
25
Disability
18
Global Health Education
15
Conflict
14
Health Financing Toolbox
12
Malaria
11
Planetary Health
10
NCDs
9
Natural Hazards
8
Rapid Response
8
Social Ethics
7
Ebola & Marburg
6
Polio
4
2.0 Rapid Response
3
Cholera
2
Zika
2
Specific Hazards
1
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group
Practical Guidance for collaborative interventions
Technical Brief
Research Article
PLOS ONE | DOI:10.1371/journal.pone.0169530 February 16, 2017
Kan M et al. Journal of the International AIDS Society 2018, 21(S5):e25139 http://onlinelibrary.wiley.com/doi/10.1002/jia2.25139/full | https://doi.org/10.1002/jia2.25139
Aлгоритм лабораторной диагностики и мониторинга лечения туберкулеза легких и туберкулеза с лекарственной устойчивостью на основе применения современных быстрых
...
PLOS ONE | DOI:10.1371/journal.pone.0144057 December 14, 2015
1-13 December 2018 | Geneva, Switzerland UNAIDS Programme Coordinating Board Issue date: 23 November 2018
UNAIDS/PCB (43)/18.32
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
HIV, viral hepatitis and STI epidemics, particularly among people who inject drugs and other key populations, continue to be fuelled by laws and policies criminalizing sex work; drug use or possession; diverse forms of gender expression and sexualit
...
Die Initiative Medikamente gegen vernachlässigte Krankheiten (Drugs for Neglected Diseases initiative, DNDi) ist eine internationale gemeinnützige Organisation, die sichere, wirksame und bezahlbare Behandlungen für die am meisten vernachlässigte
...
Guidelines for the production of extemporaenous formulations and hospital based sterile preparations
In order to streamline and effectively control compounding of medicinal products in hospitals and pharmacies, these Guidelines for Production of Extemporaneous and Hospital Based Sterile Preparations has been crafted. The purpose of these guidelines therefore is to assist pharmacists in
...
Harm reduction: evidence, impacts and challenges
-10-
EMCDDA Insights - 11
Accessed: 14.03.2019